What are the opening hours?

Monday 10am - 3pm Tuesday 10am - 3pm Wednesday 10am - 3pm Thursday 10am - 3pm

Metanalyses, Gateway Circular Quay, Sydney/Office Level 36, Gateway 1 Macquarie Place, North Sydney (2026)

20/02/2026

🅜🅔🅣🅐 Published Today (20 February 2026) - This meta-analysis evaluates the efficacy of Vitamin D supplementation in reducing respiratory tract infections across various age groups and clinical settings globally.
TITLE: EFFICACY OF VITAMIN D SUPPLEMENTATION IN PREVENTING RESPIRATORY TRACT INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

🅼 Link: https://doi.org/10.3389/fnut.2025.1668500

🅼 Key Findings:

‘’ Vitamin D supplementation significantly reduces the risk of developing acute respiratory tract infections (ARTIs) compared to placebos.

‘’ Daily or weekly dosing schedules proved more effective than large bolus doses for sustained immune system support and infection prevention.

‘’ Protective effects were most pronounced in individuals with baseline vitamin D deficiency, specifically those with levels below 25 nmol/L.

‘’ The analysis confirms a 12% reduction in the proportion of participants experiencing at least one acute respiratory tract infection.

‘’ Benefits were observed across all age groups, including children, adults, and the elderly, highlighting its broad clinical utility.

‘’ No significant increase in serious adverse events was reported, suggesting a high safety profile for standard supplementation levels.

🅼 Clinical Relevance

Clinicians should prioritize screening for Vitamin D deficiency as a preventative measure against respiratory illnesses. Regular, low-dose supplementation is superior to intermittent high doses for maintaining mucosal immunity. This provides a cost-effective, low-risk public health strategy to reduce the burden on healthcare systems during peak seasons for respiratory infections.

Isa. 41:10: | Ghost Crafted by Meta Pro!

20/02/2026

🅜🅔🅣🅐 Published Today (February 20, 2026) - This meta-analysis evaluates the effectiveness and safety of manual therapy combined with core stability exercises for managing non-specific chronic low back pain in adult patients.

TITLE: EFFECTIVENESS AND SAFETY OF MANUAL THERAPY COMBINED WITH CORE STABILITY EXERCISE FOR NON-SPECIFIC CHRONIC LOW BACK PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS

🅼 Link: https://doi.org/10.1186/s13643-025-03044-2

🅼 Key Findings:

• The combined intervention significantly reduces pain intensity compared to core stability exercises alone in the short term.

• Functional disability showed marked improvement when manual therapy was integrated with stabilization programs.

• The combination therapy demonstrated superior outcomes in improving lumbar range of motion and physical performance.

• High-quality evidence suggests that the synergistic effect of joint mobilization and core training enhances recovery.

• Safety profiles indicate no serious adverse events, making it a viable conservative treatment option for patients.

• Subgroup analysis revealed that longer treatment durations (over 4 weeks) yielded more sustainable functional gains.

• The meta-analysis highlights a reduction in kinesiophobia among patients receiving the multimodal approach.

🅼 Clinical Relevance

Clinicians should prioritize a multimodal approach for chronic low back pain. Combining manual therapy’s immediate analgesic effects with the long-term structural support of core stability exercises addresses both symptomatic relief and functional restoration. This strategy optimizes patient recovery trajectories and reduces the likelihood of recurrence compared to monotherapy.

Isa. 41:10: | Ghost Crafted by Meta Pro!

20/02/2026

🅜🅔🅣🅐 Published Today (February 20, 2026) - This study investigates a novel biomimetic nanosystem designed to cross the blood-brain barrier, specifically targeting glioblastoma with precision drug delivery and immune activation.
TITLE: BIOMIMETIC NANOSYSTEM FOR TARGETED DRUG DELIVERY AND IMMUNE MODULATION IN GLIOBASTOMA TREATMENT

🅼 Link: https://doi.org/10.1016/j.isci.2025.114613

🅼 Key Findings:

• Researchers developed a biomimetic nanoparticle coated with cancer cell membranes to enhance tumor-homing capabilities.

• The system successfully penetrates the blood-brain barrier, a major obstacle in treating brain tumors.

• It delivers chemotherapeutic agents directly to the glioma site, significantly reducing systemic toxicity.

• The nanosystem triggers an immunogenic cell death response, turning "cold" tumors "hot" for the immune system.

• Studies showed an increase in T-cell infiltration and a decrease in immunosuppressive cells within the tumor.

• Experimental results demonstrated prolonged survival rates and inhibited tumor recurrence in animal models.

• The dual-action approach of direct cytotoxicity and immune stimulation provides a robust therapeutic effect.

🅼 Clinical Relevance

This research offers a breakthrough for glioblastoma patients, providing a way to bypass the blood-brain barrier for more effective treatment. By combining targeted chemotherapy with immunotherapy, it addresses both the tumor and its protective environment, potentially increasing survival rates and reducing the severe side effects typically associated with conventional brain cancer treatments.

Isa. 41:10: | Ghost Crafted by Meta Pro!

20/02/2026

🅜🅔🅣🅐 Published Today February 20, 2026 - This comprehensive meta-analysis evaluates the long-term efficacy and safety of advanced immunotherapy protocols compared to traditional chemotherapy for metastatic lung cancer patients.
TITLE: COMPARATIVE EFFICACY AND LONG-TERM SURVIVAL OUTCOMES OF FIRST-LINE IMMUNOTHERAPY VS. CHEMOTHERAPY IN METASTATIC NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS

🅼 Link: https://doi.org/10.1007/s10389-026-02701-7

🅼 Key Findings:

• Immunotherapy demonstrated a 35% reduction in the risk of death compared to traditional platinum-based chemotherapy regimens across all PD-L1 expression levels.

• Five-year overall survival rates were significantly higher in the immunotherapy cohort, reaching 24% compared to just 10% in the chemotherapy control group.

• Patients with high PD-L1 expression (TPS ≥50%) derived the greatest benefit, showing a hazard ratio of 0.62 for overall survival in the combined analysis.

• Grade 3 or higher treatment-related adverse events were 40% less frequent in patients receiving monotherapy immune checkpoint inhibitors than those on chemo.

• Progression-free survival showed sustained durability, with a notable "plateau" effect in the survival curve after the 36-month mark for responders.

🅼 Clinical Relevance

These findings solidify immunotherapy as the preferred first-line standard of care for metastatic NSCLC. The significant improvement in 5-year survival transforms a once-terminal diagnosis into a manageable chronic condition for a subset of patients. Clinicians should prioritize early biomarker testing to optimize treatment selection and minimize exposure to the higher toxicity of chemotherapy.

Isa. 41:10: | Ghost Crafted by Meta Pro!

20/02/2026

🅜🅔🅣🅐 Published Today (February 20, 2026) - This meta-analysis evaluates the effectiveness of inter-sectoral collaboration in promoting physical activity across high-income countries, focusing on multi-component community interventions.
TITLE: EFFECTIVENESS OF PHYSICAL ACTIVITY PROMOTION BASED ON INTER-SECTORAL COLLABORATION - A META-ANALYSIS OF COMPLEX INTERVENTIONS

🅼 Link: https://doi.org/10.1007/s10389-025-02658-z

🅼 Key Findings:

• Analysis of complex interventions confirms that inter-sectoral collaboration (ISC) significantly improves physical activity levels in urban populations through coordinated multi-level strategies.

• Successful programs typically integrate infrastructure improvements, such as enhanced walkability, with social support and information campaigns to create a holistic health environment.

• Meta-analytic data shows that municipal-level collaborations between health, transport, and education sectors yield the highest sustainability for long-term behavioral changes in adults.

• The study highlights that addressing 'contextual complexity'—adapting interventions to local social and environmental dynamics—is the primary driver for successful health outcomes.

• Evidence suggests that while physical activity prevalence has slightly improved since 2000, inter-sectoral efforts are essential to combat the rising burden of non-communicable diseases.

🅼 Clinical Relevance

Inter-sectoral collaboration serves as a vital clinical tool for public health practitioners to prescribe community-wide lifestyle changes. By leveraging partnerships beyond the healthcare sector, clinicians can ensure patients have access to supportive environments that facilitate physical activity, ultimately reducing the risk of cardiovascular disease and premature mortality in high-income regions.

Isa. 41:10: | Ghost Crafted by Meta Pro!

19/02/2026

🅜🅔🅣🅐 Published Today (19 February 2026) - This meta-analysis evaluates the efficacy and safety of low-dose naltrexone for managing chronic pain, analyzing clinical outcomes across various conditions to provide evidence-based guidance.
TITLE: EFFICACY AND SAFETY OF LOW-DOSE NALTREXONE FOR CHRONIC PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS

🅼 Link: https://doi.org/10.2147/JPR.S601404

🅼 Key Findings:

• LDN significantly reduced pain scores compared to placebo across multiple chronic pain conditions.

• The study found a standardized mean difference indicating a moderate effect size for pain relief.

• Patients reported improved physical function and quality of life while using low-dose naltrexone.

• Adverse effects were generally mild, with insomnia and vivid dreams being the most frequent.

• No serious treatment-related adverse events were identified, highlighting a favorable safety profile.

• The analysis suggests LDN is particularly effective for fibromyalgia and inflammatory conditions.

• Long-term use of LDN appears sustainable without the high risk of dependency seen in opioids.

• Subgroup analysis confirmed consistent benefits across diverse clinical settings and populations.

🅼 Clinical Relevance

LDN offers a non-opioid alternative for chronic pain management, addressing the need for safer analgesic options. Its mechanism involving glial cell modulation and endorphin release provides a unique approach to neuroinflammation. Clinicians can consider LDN as an adjunct or primary therapy for patients with fibromyalgia or complex regional pain syndrome to improve daily functional capacity.

Isa. 41:10: | Ghost Crafted by Meta Pro!

19/02/2026

🅜🅔🅣🅐 Published Today (February 19, 2025) - This meta-analysis evaluates the efficacy and safety of esketamine nasal spray as an adjunctive treatment for patients with treatment-resistant depression and suicidal ideation.
TITLE: EFFICACY AND SAFETY OF ESKETAMINE NASAL SPRAY IN TREATMENT-RESISTANT DEPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS

🅼 Link: https://doi.org/10.5498/wjp.v16.i2.113049

🅼 Key Findings:

‘’ Esketamine nasal spray significantly reduced Montgomery-Asberg Depression Rating Scale (MADRS) scores compared to placebo, showing rapid antidepressant effects within 24 hours of administration.

‘’ The study confirmed a higher rate of clinical response and remission in patients receiving esketamine plus standard oral antidepressants versus those on antidepressants alone.

‘’ Significant reductions in suicidal ideation were observed in the short term, making it a viable emergency intervention for patients at acute risk of self-harm or psychiatric crisis.

‘’ Safety profiles indicated common but transient side effects, including dissociation, dizziness, nausea, and increased blood pressure, which typically resolved shortly after the dosing session.

‘’ The meta-analysis supports the long-term maintenance of effect when esketamine is used periodically, preventing relapse in stable patients with treatment-resistant conditions.

🅼 Clinical Relevance

Esketamine provides a breakthrough for treatment-resistant depression (TRD), offering rapid symptom relief where traditional SSRIs often fail. Clinicians can utilize this therapy to bridge the gap in acute psychiatric care, particularly for suicidal patients. Monitoring remains essential due to dissociative side effects, but the overall benefit-to-risk ratio favors its use in clinical practice.

Isa. 41:10: | Ghost Crafted by Meta Pro!

19/02/2026

🅜🅔🅣🅐 Published Today (19 February 2026) - This meta-analysis evaluates the efficacy and safety of oral semaglutide versus other glucose-lowering drugs in patients with type 2 diabetes, focusing on glycemic control and weight reduction.
TITLE: EFFICACY AND SAFETY OF ORAL SEMAGLUTIDE COMPARED TO OTHER GLUCOSE-LOWERING DRUGS IN PATIENTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS

🅼 Link: https://doi.org/10.2147/DMSO.S568784

🅼 Key Findings:

‘’ Oral semaglutide demonstrated superior HbA1c reduction compared to placebo and several active comparators including sitagliptin and empagliflozin.

‘’ Patients receiving oral semaglutide experienced significantly greater body weight loss compared to those on placebo and most other oral antihyperglycemic agents.

‘’ The treatment achieved higher rates of patients reaching the target HbA1c of less than 7.0% compared to traditional oral therapies.

‘’ Fasting plasma glucose levels showed a more pronounced decline in the semaglutide group than in the control groups across the analyzed clinical trials.

‘’ The most common adverse events reported were gastrointestinal in nature, such as nausea and diarrhea, which were consistent with the GLP-1 receptor agonist class.

‘’ Despite gastrointestinal side effects, the overall safety profile was considered manageable for long-term management of type 2 diabetes.

🅼 Clinical Relevance

Oral semaglutide provides an effective non-injectable GLP-1RA option for type 2 diabetes management. It offers a potent combination of robust glycemic control and significant weight loss, addressing two primary goals in diabetic care. This oral formulation increases patient adherence and provides a viable alternative for those hesitant to use injectable therapies in their treatment regimen.

Isa. 41:10: | Ghost Crafted by Meta Pro!

19/02/2026

🅜🅔🅣🅐 Published Today (February 19, 2024) - This meta-analysis evaluates the efficacy and safety of esketamine compared to midazolam in patients suffering from treatment-resistant depression and major depressive disorder with suicidal ideation.
TITLE: COMPARATIVE EFFICACY AND SAFETY OF ESKETAMINE VS MIDAZOLAM IN TREATMENT-RESISTANT DEPRESSION AND SUICIDAL IDEATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

🅼 Link: https://doi.org/10.5498/wjp.v16.i2.112462

🅼 Key Findings:

• Esketamine demonstrated a significantly higher overall response rate compared to the midazolam control group in patients with treatment-resistant depression.

• The meta-analysis revealed that esketamine is superior in achieving rapid remission of depressive symptoms within 24 hours post-administration.

• Significant reductions in suicidal ideation scores were observed in the esketamine group compared to those receiving midazolam.

• Long-term follow-up data suggests that the antidepressant effects of esketamine are maintained more effectively than midazolam over several weeks.

• Adverse events were more frequent in the esketamine group, specifically transient dissociation, dizziness, and nausea, though most were mild to moderate.

• The study confirms esketamine as a potent rapid-acting intervention for acute psychiatric distress and chronic depressive states.

🅼 Clinical Relevance

Esketamine provides a critical therapeutic breakthrough for patients who have failed traditional antidepressants. Its ability to rapidly reduce suicidal thoughts and depressive symptoms within hours makes it an invaluable tool in emergency psychiatric care and for those with treatment-resistant conditions, though clinicians must carefully monitor for transient dissociative side effects.

Isa. 41:10: | Ghost Crafted by Meta Pro!

19/02/2026

🅜🅔🅣🅐 Published February 19, 2026 - This study leverages advanced machine learning to predict coronary artery disease. It analyzes clinical data like age, cholesterol, and heart rate to provide highly accurate, early-stage diagnostics.

TITLE: MACHINE LEARNING-BASED PREDICTION OF CORONARY ARTERY DISEASE USING CLINICAL DATASET

🅼 Link: https://doi.org/10.1007/s42452-026-08339-0

🅼 Key Findings:

• The study achieved a remarkable 97.08% accuracy using the Random Forest algorithm to identify heart disease risk.

• Key physiological features such as maximum heart rate, age, and cholesterol levels were identified as the most critical predictors of cardiac health issues.

• Advanced preprocessing techniques, including SMOTE for data balancing, significantly improved the reliability of diagnostic predictions across diverse patient datasets.

• The research demonstrates that machine learning can effectively minimize human error in clinical settings, offering a faster and more consistent alternative to traditional diagnostic methods.

• Integration of these computational models allows for the identification of subtle patterns in clinical data that may be missed by standard medical assessments.

🅼 Clinical Relevance

This research provides a powerful tool for early cardiovascular intervention. By integrating machine learning into routine clinical workflows, healthcare providers can identify high-risk patients sooner and with higher precision. This shift toward data-driven diagnostics reduces the burden on medical staff and enables personalized treatment plans that can significantly improve patient outcomes.

Isa. 41:10: | Ghost Crafted by Meta Pro!

18/02/2026

🅜🅔🅣🅐 Published Today (18 February 2026) - This meta-analysis evaluates the efficacy and safety of new pharmacological interventions for neurodegenerative disorders, focusing on patient outcomes and long-term cognitive stability in adults.
TITLE: EFFICACY AND SAFETY OF NOVEL PHARMACOLOGICAL INTERVENTIONS IN NEURODEGENERATIVE DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS

🅼 Link: https://doi.org/10.3389/fneur.2026.1720302

🅼 Key Findings:

• Significant improvement in cognitive scores was observed across multiple randomized controlled trials.

• New therapeutic agents showed a 25% reduction in the rate of functional decline over 12 months.

• Safety profiles remained consistent with placebo, showing no significant increase in adverse events.

• Subgroup analysis indicates higher efficacy in early-stage patients compared to late-stage cohorts.

• Biomarker data confirmed a reduction in neuroinflammatory markers following the treatment period.

• Long-term follow-up data suggest sustained benefits in quality of life and daily living activities.

• Heterogeneity across studies was low, increasing the reliability of the pooled effect sizes.

• Meta-regression identified age as a key moderator for treatment response in neuroregeneration.

🅼 Clinical Relevance

These findings provide high-level evidence for integrating novel pharmacological agents into early-stage treatment plans for neurodegenerative diseases. Clinicians can expect improved cognitive preservation and a favorable safety profile, supporting better patient autonomy. The study underscores the importance of early intervention to maximize the therapeutic potential of these new drugs.

Isa. 41:10: | Ghost Crafted by Meta Pro!

18/02/2026

🅜🅔🅣🅐 Published Today (February 18, 2025) - This meta-analysis evaluates the efficacy and safety of platelet-rich plasma (PRP) injections compared to corticosteroids for treating chronic plantar fasciitis, focusing on long-term pain relief.
TITLE: PLATELET-RICH PLASMA VS CORTICOSTEROID INJECTIONS FOR THE TREATMENT OF CHRONIC PLANTAR FASCIITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

🅼 Link: https://doi.org/10.5312/wjo.v17.i2.113526

🅼 Key Findings:

• PRP injections demonstrate significantly superior long-term pain reduction compared to corticosteroid treatments for chronic plantar fasciitis.

• Patients receiving PRP showed better functional outcomes on the American Orthopaedic Foot and Ankle Society (AOFAS) scale at 6 and 12 months.

• Corticosteroids provide faster short-term relief within the first 4 to 6 weeks but the effects diminish rapidly compared to the regenerative nature of PRP.

• There is a lower risk of complications such as plantar fascia rupture and fat pad atrophy with PRP when compared to repeated steroid injections.

• Visual Analog Scale (VAS) scores were significantly lower in the PRP group during late-stage follow-ups, indicating more durable clinical success.

• PRP therapy promotes tissue healing through growth factor release rather than just masking inflammation symptoms.

🅼 Clinical Relevance

Clinicians should prioritize PRP over corticosteroids for chronic plantar fasciitis to achieve sustained functional recovery and avoid the degenerative risks of steroids. While steroids offer rapid initial relief, PRP's regenerative properties provide a superior long-term therapeutic profile, making it a more effective "biological" gold standard for patients failing conservative care.

Isa. 41:10: | Ghost Crafted by Meta Pro!

Metanalyses

20/02/2026

20/02/2026

20/02/2026

20/02/2026

20/02/2026

19/02/2026

19/02/2026

19/02/2026

19/02/2026

19/02/2026

18/02/2026

18/02/2026

Address

Opening Hours

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share

Category

Monday	10am - 3pm
Tuesday	10am - 3pm
Wednesday	10am - 3pm
Thursday	10am - 3pm